Online Medical Diagnosis of Medical Problems and Symptoms - The National Medical Society


Initiate Treatment with Fluvoxamine


Thirty patients with GSAD were treated with fluvoxamine, 50 to 150 mg/d, in a randomized double-blind, placebo-controlled study during 12 weeks by van Vliet et al. Fluvoxamine was statistically superior to placebo on all outcome measures. In the study, 46% of the fluvoxamine-treated patients and 7% of placebo patients were deemed responders.

Further Treatment


Sarah J. Thompson, MD


Online Diagnosis of Symptoms and Medical Diseases 

Online Diagnosis of  Psychiatric Disorders 

New Treatments




Online treatment advisor for medical and psychiatric disorders